UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $622,000 | +229.1% | 71,392 | +258.5% | 0.00% | – |
| Q4 2021 | $189,000 | -84.2% | 19,912 | -72.0% | 0.00% | -100.0% |
| Q3 2021 | $1,195,000 | +20.1% | 71,045 | +9.0% | 0.00% | 0.0% |
| Q2 2021 | $995,000 | +247.9% | 65,179 | +343.7% | 0.00% | – |
| Q1 2021 | $286,000 | -44.9% | 14,690 | -49.0% | 0.00% | – |
| Q4 2020 | $519,000 | -5.3% | 28,819 | +1.4% | 0.00% | – |
| Q3 2020 | $548,000 | -17.2% | 28,423 | +12.2% | 0.00% | -100.0% |
| Q2 2020 | $662,000 | +49.8% | 25,328 | +2.3% | 0.00% | – |
| Q1 2020 | $442,000 | -36.8% | 24,749 | +18.1% | 0.00% | -100.0% |
| Q4 2019 | $699,000 | +48.7% | 20,957 | +6.3% | 0.00% | – |
| Q3 2019 | $470,000 | +114.6% | 19,720 | +223.7% | 0.00% | – |
| Q2 2019 | $219,000 | – | 6,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |